Neurokinin-1 Receptor Antagonists against Hepatoblastoma
Hepatoblastoma (HB) is the most common malignant liver tumor that occurs during childhood. The prognosis of children with HB is favorable when a complete surgical resection of the tumor is possible, but for high-risk patients, the prognosis is much worse. New anti-HB strategies must be urgently deve...
Main Authors: | Miguel Muñoz, Marisa Rosso, Rafael Coveñas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/9/1258 |
Similar Items
-
The Neurokinin-1 Receptor Antagonist Aprepitant: An Intelligent Bullet against Cancer?
by: Miguel Muñoz, et al.
Published: (2020-09-01) -
The Neurokinin-1 Receptor Antagonist Aprepitant, a New Drug for the Treatment of Hematological Malignancies: Focus on Acute Myeloid Leukemia
by: Miguel Muñoz, et al.
Published: (2020-06-01) -
The NK-1 Receptor Antagonist L-732,138 Induces Apoptosis and Counteracts Substance P-Related Mitogenesis in Human Melanoma Cell Lines
by: Miguel Muñoz, et al.
Published: (2010-04-01) -
Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant
by: Tatevik Ohanyan, et al.
Published: (2017-09-01) -
Neurokinin-1 receptor antagonists as antitumor drugs in gastrointestinal cancer: A new approach
by: Miguel Muñoz, et al.
Published: (2016-01-01)